Streetwise Life Sciences Tools & Diagnostics Articles


Biotech Enters License Agreement to Validate Biomarker as Alternative NASH Diagnostic

Research Report
  ()
The background and justification for the deal was covered in an H.C. Wainwright & Co. report. read more >

Telehealth Services Provider's Positive Q3/18 Results Reflect 'Robust Growth Rate'

Research Report
  ()
A William Blair report reviewed the firm's operational and financial numbers for the period. read more >

Health Stock 'Looking Set to Bounce Back After 90% Drop'

Contributed Opinion
  ()
Technical analyst Clive Maund charts a telemedicine technology company and explains why he believes the company's stock should rebound. read more >

Biotech to Expand Precision Medicine Services via New Partnership

Research Report
  ()
A Maxim Group report discussed the potential implications of this new collaboration in the field of personalized medicine and oncology. read more >
News Update

Developer of Nitric Oxide Delivery Devices Rebrands to Focus on Leading Advancements

News Update
  ()
This Utah-based company rolled out an online campaign that highlights its strategic repositioning. read more >

Interim Readout for Pharma Trial 'Delivers Home Run'

Research Report
  ()
An H.C. Wainwright & Co. report discussed the implications of data indicating "overwhelming evidence of efficacy" for this company's nonantibiotic anti-infective for treatment of catheter-related bloodstream infections. read more >
News Update

Healthcare Tech Company Receives US Patent

News Update
  ()
The U.S Patent and Trademark Office has granted the allowance to a technology company whose platform allows healthcare organizations to buy, sell and trade equipment and supplies. read more >
Showing Results: 1 to 7 of 7

Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts

"DRRX will move its alcoholic hepatitis program to Dr. Craig McClain." ❭
– Patrick Dolezal, LifeSci Capital